Endocyte Announces Closing of Upsized Public Offering and Exercise of Over …

Of the total shares in the offering, 5839810 shares were sold by Endocyte, which includes the exercise in full by the underwriters of their option to purchase up to 871489 additional shares at the public offering price, less underwriting discounts and …
See all stories on this topic »